| __timestamp | CymaBay Therapeutics, Inc. | Opthea Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 15823000 | 3401685 |
| Thursday, January 1, 2015 | 17026000 | 4284228 |
| Friday, January 1, 2016 | 15941000 | 3581295 |
| Sunday, January 1, 2017 | 18938000 | 4838300 |
| Monday, January 1, 2018 | 58124000 | 24891534 |
| Tuesday, January 1, 2019 | 83837000 | 31347891 |
| Wednesday, January 1, 2020 | 35882000 | 17480747 |
| Friday, January 1, 2021 | 64542000 | 34710152 |
| Saturday, January 1, 2022 | 67995000 | 108459978 |
| Sunday, January 1, 2023 | 80118000 | 181563523 |
| Monday, January 1, 2024 | 176326321 |
Unleashing the power of data
In the ever-evolving world of biotechnology, research and development (R&D) spending is a key indicator of a company's commitment to innovation. Over the past decade, CymaBay Therapeutics, Inc. and Opthea Limited have demonstrated varying levels of investment in R&D, reflecting their strategic priorities.
From 2014 to 2023, CymaBay Therapeutics, Inc. consistently increased its R&D spending, peaking in 2023 with a 407% increase from its 2014 levels. Opthea Limited, on the other hand, showed a dramatic surge in 2022, with R&D expenses rising by over 3000% compared to 2014, reaching their highest in 2023. This suggests a recent strategic pivot towards innovation.
While CymaBay's growth in R&D spending has been steady, Opthea's recent spike indicates a bold move to catch up in the competitive biotech landscape. Missing data for 2024 suggests ongoing developments that could further shift these trends.
Who Prioritizes Innovation? R&D Spending Compared for Takeda Pharmaceutical Company Limited and Opthea Limited
Research and Development: Comparing Key Metrics for Genmab A/S and CymaBay Therapeutics, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Madrigal Pharmaceuticals, Inc. and CymaBay Therapeutics, Inc.
R&D Spending Showdown: Opthea Limited vs Amneal Pharmaceuticals, Inc.
Analyzing R&D Budgets: Opthea Limited vs Catalyst Pharmaceuticals, Inc.
Analyzing R&D Budgets: Opthea Limited vs ImmunityBio, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Opthea Limited and Ligand Pharmaceuticals Incorporated
Analyzing R&D Budgets: Opthea Limited vs Supernus Pharmaceuticals, Inc.
R&D Insights: How Opthea Limited and Wave Life Sciences Ltd. Allocate Funds
Research and Development Expenses Breakdown: CymaBay Therapeutics, Inc. vs Rhythm Pharmaceuticals, Inc.
CymaBay Therapeutics, Inc. vs Veracyte, Inc.: Strategic Focus on R&D Spending
Comparing Innovation Spending: CymaBay Therapeutics, Inc. and Viridian Therapeutics, Inc.